The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial

A. Masurekar; C. Fong; A. Hussein; T. Revesz; P. M. Hoogerbrugge; S. Love; C. Ciria; C. Parker; S. Krishnan; V. Saha

doi:10.1038/bcj.2014.26

The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial

A. Masurekar
, C. Fong
, A. Hussein
, T. Revesz
, P. M. Hoogerbrugge
, S. Love
, C. Ciria
, C. Parker
, S. Krishnan
, V. Saha

Research output: Contribution to journal › Letter › peer-review

9 Citations (Scopus)

Original language	English
Article number	e203
Journal	Blood cancer journal
Volume	4
Issue number	4
DOIs	https://doi.org/10.1038/bcj.2014.26
Publication status	Published - Apr 2014
Externally published	Yes

Access to Document

10.1038/bcj.2014.26

Cite this

@article{02c8ccfdbae849f29970779375919fcc,

title = "The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial",

author = "A. Masurekar and C. Fong and A. Hussein and T. Revesz and Hoogerbrugge, \{P. M.\} and S. Love and C. Ciria and C. Parker and S. Krishnan and V. Saha",

year = "2014",

month = apr,

doi = "10.1038/bcj.2014.26",

language = "English",

volume = "4",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "4",

}

TY - JOUR

T1 - The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial

AU - Masurekar, A.

AU - Fong, C.

AU - Hussein, A.

AU - Revesz, T.

AU - Hoogerbrugge, P. M.

AU - Love, S.

AU - Ciria, C.

AU - Parker, C.

AU - Krishnan, S.

AU - Saha, V.

PY - 2014/4

Y1 - 2014/4

UR - https://www.scopus.com/pages/publications/84901938517

U2 - 10.1038/bcj.2014.26

DO - 10.1038/bcj.2014.26

M3 - Letter

C2 - 24769644

AN - SCOPUS:84901938517

SN - 2044-5385

VL - 4

JO - Blood cancer journal

JF - Blood cancer journal

IS - 4

M1 - e203

ER -